Frequencies for first 10,000 rows of indi_pt variable in indi2015q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal discomfort | 17 0.17 0.17 Abdominal pain | 2 0.02 0.19 Abdominal pain upper | 4 0.04 0.23 Abnormal behaviour | 2 0.02 0.25 Abnormal dreams | 1 0.01 0.26 Abscess | 6 0.06 0.32 Acidosis | 1 0.01 0.33 Acne | 30 0.30 0.63 Acne cystic | 3 0.03 0.66 Acral overgrowth | 3 0.03 0.69 Acromegaly | 5 0.05 0.74 Acute coronary syndrome | 11 0.11 0.85 Acute graft versus host disease | 1 0.01 0.86 Acute leukaemia | 1 0.01 0.87 Acute lymphocytic leukaemia | 8 0.08 0.95 Acute myeloid leukaemia | 12 0.12 1.07 Acute myocardial infarction | 38 0.38 1.45 Addison's disease | 2 0.02 1.47 Adenocarcinoma | 3 0.03 1.50 Adenocarcinoma gastric | 8 0.08 1.58 Adenocarcinoma of colon | 4 0.04 1.62 Adenocarcinoma pancreas | 3 0.03 1.65 Adjuvant therapy | 5 0.05 1.70 Adnexa uteri pain | 1 0.01 1.71 Adrenocortical carcinoma | 2 0.02 1.73 Affective disorder | 5 0.05 1.78 Age-related macular degeneration | 3 0.03 1.81 Aggression | 8 0.08 1.89 Agitation | 27 0.27 2.16 Alagille syndrome | 1 0.01 2.17 Alcohol abuse | 1 0.01 2.18 Alopecia | 56 0.56 2.74 Amenorrhoea | 1 0.01 2.75 Amyloidosis | 1 0.01 2.76 Amyotrophic lateral sclerosis | 2 0.02 2.78 Anaemia | 11 0.11 2.89 Anaemia of malignant disease | 2 0.02 2.91 Anaemia prophylaxis | 1 0.01 2.92 Anal cancer | 2 0.02 2.94 Analgesic therapy | 3 0.03 2.97 Anaplastic astrocytoma | 4 0.04 3.01 Androgen deficiency | 2 0.02 3.03 Androgenetic alopecia | 33 0.33 3.36 Aneurysm | 1 0.01 3.37 Angina pectoris | 14 0.14 3.51 Angina unstable | 1 0.01 3.52 Angiomyolipoma | 3 0.03 3.55 Angiopathy | 1 0.01 3.56 Ankle fracture | 2 0.02 3.58 Ankylosing spondylitis | 34 0.34 3.92 Antacid therapy | 1 0.01 3.93 Antibiotic prophylaxis | 5 0.05 3.98 Antibiotic therapy | 3 0.03 4.01 Anticoagulant therapy | 29 0.29 4.30 Antidepressant therapy | 7 0.07 4.37 Antiemetic supportive care | 2 0.02 4.39 Antifungal prophylaxis | 4 0.04 4.43 Antifungal treatment | 1 0.01 4.44 Antiinflammatory therapy | 2 0.02 4.46 Antiphospholipid antibodies | 1 0.01 4.47 Antiphospholipid syndrome | 3 0.03 4.50 Antiplatelet therapy | 14 0.14 4.64 Antiretroviral therapy | 1 0.01 4.65 Antitussive therapy | 2 0.02 4.67 Antiviral prophylaxis | 5 0.05 4.72 Antiviral treatment | 6 0.06 4.78 Anxiety | 96 0.96 5.74 Anxiety disorder | 3 0.03 5.77 Arrhythmia | 7 0.07 5.84 Arterial occlusive disease | 2 0.02 5.86 Arteriosclerosis | 2 0.02 5.88 Arteriosclerosis coronary artery | 2 0.02 5.90 Arthralgia | 18 0.18 6.08 Arthritis | 16 0.16 6.24 Arthrodesis | 1 0.01 6.25 Arthropathy | 1 0.01 6.26 Aspergillus infection | 1 0.01 6.27 Asthenia | 1 0.01 6.28 Asthma | 242 2.42 8.70 Asthmatic crisis | 2 0.02 8.72 Astrocytoma, low grade | 2 0.02 8.74 Atelectasis | 1 0.01 8.75 Atrial fibrillation | 36 0.36 9.11 Atrial flutter | 1 0.01 9.12 Atrioventricular block complete | 2 0.02 9.14 Attention deficit/hyperactivity disor.. | 8 0.08 9.22 Autoimmune disorder | 1 0.01 9.23 Autoimmune haemolytic anaemia | 9 0.09 9.32 Azotaemia | 39 0.39 9.71 B-cell lymphoma | 9 0.09 9.80 Back disorder | 2 0.02 9.82 Back pain | 24 0.24 10.06 Bacterial vaginosis | 1 0.01 10.07 Balance disorder | 1 0.01 10.08 Barrett's oesophagus | 21 0.21 10.29 Bedridden | 1 0.01 10.30 Benign prostatic hyperplasia | 12 0.12 10.42 Bile duct cancer | 1 0.01 10.43 Bipolar I disorder | 15 0.15 10.58 Bipolar disorder | 54 0.54 11.12 Bladder cancer | 8 0.08 11.20 Bladder disorder | 1 0.01 11.21 Bladder dysfunction | 1 0.01 11.22 Bladder spasm | 1 0.01 11.23 Bladder transitional cell carcinoma | 1 0.01 11.24 Blepharitis | 1 0.01 11.25 Blood cholesterol | 16 0.16 11.41 Blood cholesterol abnormal | 41 0.41 11.82 Blood cholesterol increased | 49 0.49 12.31 Blood count | 1 0.01 12.32 Blood disorder | 4 0.04 12.36 Blood glucose abnormal | 4 0.04 12.40 Blood glucose increased | 1 0.01 12.41 Blood growth hormone decreased | 1 0.01 12.42 Blood immunoglobulin E increased | 1 0.01 12.43 Blood iron decreased | 1 0.01 12.44 Blood magnesium decreased | 1 0.01 12.45 Blood potassium | 1 0.01 12.46 Blood potassium abnormal | 1 0.01 12.47 Blood potassium decreased | 3 0.03 12.50 Blood potassium increased | 1 0.01 12.51 Blood pressure abnormal | 55 0.55 13.06 Blood pressure increased | 10 0.10 13.16 Blood pressure management | 1 0.01 13.17 Blood pressure measurement | 11 0.11 13.28 Blood pressure systolic | 1 0.01 13.29 Blood thyroid stimulating hormone dec.. | 2 0.02 13.31 Blood thyroid stimulating hormone inc.. | 1 0.01 13.32 Blood triglycerides abnormal | 5 0.05 13.37 Blood triglycerides increased | 21 0.21 13.58 Body height below normal | 14 0.14 13.72 Bone cancer | 16 0.16 13.88 Bone density decreased | 16 0.16 14.04 Bone development abnormal | 2 0.02 14.06 Bone disorder | 5 0.05 14.11 Bone graft | 1 0.01 14.12 Bone loss | 2 0.02 14.14 Bone marrow conditioning regimen | 5 0.05 14.19 Bone marrow failure | 2 0.02 14.21 Bone marrow transplant | 10 0.10 14.31 Bone pain | 8 0.08 14.39 Bordetella infection | 3 0.03 14.42 Brain cancer metastatic | 1 0.01 14.43 Brain injury | 1 0.01 14.44 Brain neoplasm | 3 0.03 14.47 Brain neoplasm benign | 3 0.03 14.50 Brain neoplasm malignant | 33 0.33 14.83 Brain stem glioma | 2 0.02 14.85 Breakthrough pain | 1 0.01 14.86 Breast cancer | 91 0.91 15.77 Breast cancer female | 92 0.92 16.69 Breast cancer metastatic | 29 0.29 16.98 Breast cancer stage III | 3 0.03 17.01 Bronchial carcinoma | 5 0.05 17.06 Bronchial disorder | 1 0.01 17.07 Bronchial hyperreactivity | 2 0.02 17.09 Bronchiectasis | 4 0.04 17.13 Bronchiolitis | 1 0.01 17.14 Bronchitis | 31 0.31 17.45 Bronchitis chronic | 5 0.05 17.50 Bronchopulmonary aspergillosis | 1 0.01 17.51 Burning sensation | 2 0.02 17.53 Bursitis | 1 0.01 17.54 CHARGE syndrome | 1 0.01 17.55 Cachexia | 1 0.01 17.56 Calcium deficiency | 1 0.01 17.57 Cancer pain | 8 0.08 17.65 Candida endophthalmitis | 2 0.02 17.67 Candida infection | 1 0.01 17.68 Carcinoid syndrome | 1 0.01 17.69 Carcinoid tumour | 2 0.02 17.71 Cardiac disorder | 42 0.42 18.13 Cardiac failure | 100 1.00 19.13 Cardiac failure chronic | 12 0.12 19.25 Cardiac failure congestive | 14 0.14 19.39 Cardiac operation | 1 0.01 19.40 Cardiac pacemaker insertion | 1 0.01 19.41 Cardiogenic shock | 3 0.03 19.44 Cardiomyopathy | 1 0.01 19.45 Cardiovascular disorder | 8 0.08 19.53 Cardiovascular event prophylaxis | 3 0.03 19.56 Carpal tunnel syndrome | 2 0.02 19.58 Cellulitis | 1 0.01 19.59 Central nervous system neoplasm | 2 0.02 19.61 Cerebral infarction | 2 0.02 19.63 Cerebral thrombosis | 1 0.01 19.64 Cerebrovascular accident | 11 0.11 19.75 Cerebrovascular accident prophylaxis | 2 0.02 19.77 Cervicobrachial syndrome | 1 0.01 19.78 Cervix carcinoma | 3 0.03 19.81 Chalazion | 2 0.02 19.83 Cheilitis | 1 0.01 19.84 Chemotherapy | 9 0.09 19.93 Chest pain | 9 0.09 20.02 Chlamydial infection | 1 0.01 20.03 Cholangiocarcinoma | 4 0.04 20.07 Cholecystitis | 1 0.01 20.08 Chondrosarcoma | 2 0.02 20.10 Chronic gastritis | 1 0.01 20.11 Chronic graft versus host disease | 1 0.01 20.12 Chronic granulomatous disease | 1 0.01 20.13 Chronic hepatitis | 1 0.01 20.14 Chronic hepatitis B | 1 0.01 20.15 Chronic hepatitis C | 19 0.19 20.34 Chronic inflammatory demyelinating po.. | 1 0.01 20.35 Chronic kidney disease | 45 0.45 20.80 Chronic lymphocytic leukaemia | 30 0.30 21.10 Chronic lymphocytic leukaemia transfo.. | 1 0.01 21.11 Chronic myeloid leukaemia | 49 0.49 21.60 Chronic obstructive pulmonary disease | 101 1.01 22.61 Clear cell sarcoma of soft tissue | 1 0.01 22.62 Coagulopathy | 1 0.01 22.63 Colitis | 1 0.01 22.64 Colitis ulcerative | 36 0.36 23.00 Collagen disorder | 1 0.01 23.01 Colon cancer | 30 0.30 23.31 Colon cancer metastatic | 2 0.02 23.33 Colorectal cancer | 19 0.19 23.52 Colorectal cancer metastatic | 22 0.22 23.74 Complications of bone marrow transplant | 1 0.01 23.75 Computerised tomogram | 1 0.01 23.76 Confusional state | 3 0.03 23.79 Congenital absence of bile ducts | 2 0.02 23.81 Congenital endocrine anomaly | 1 0.01 23.82 Congenital hypothyroidism | 1 0.01 23.83 Congestive cardiomyopathy | 3 0.03 23.86 Conjunctivitis allergic | 2 0.02 23.88 Connective tissue disorder | 2 0.02 23.90 Constipation | 26 0.26 24.16 Constipation prophylaxis | 2 0.02 24.18 Contraception | 57 0.57 24.75 Convulsion prophylaxis | 1 0.01 24.76 Cor pulmonale chronic | 6 0.06 24.82 Coronary artery disease | 14 0.14 24.96 Cough | 14 0.14 25.10 Crohn's disease | 53 0.53 25.63 Cryoglobulinaemia | 2 0.02 25.65 Cryopyrin associated periodic syndrome | 2 0.02 25.67 Cushing's syndrome | 4 0.04 25.71 Cystic fibrosis | 22 0.22 25.93 Cystic fibrosis pancreatic | 3 0.03 25.96 Cystinosis | 1 0.01 25.97 Cystitis | 2 0.02 25.99 Cytomegalovirus chorioretinitis | 2 0.02 26.01 Decreased appetite | 1 0.01 26.02 Deep vein thrombosis | 6 0.06 26.08 Dehydration | 2 0.02 26.10 Delayed puberty | 1 0.01 26.11 Dementia | 2 0.02 26.13 Dementia Alzheimer's type | 4 0.04 26.17 Dental cosmetic procedure | 2 0.02 26.19 Depression | 159 1.59 27.78 Depressive symptom | 2 0.02 27.80 Dermatitis | 5 0.05 27.85 Dermatitis atopic | 4 0.04 27.89 Dermatomyositis | 2 0.02 27.91 Developmental delay | 1 0.01 27.92 Device related infection | 2 0.02 27.94 Device therapy | 1 0.01 27.95 Diabetes mellitus | 86 0.86 28.81 Diabetes mellitus inadequate control | 1 0.01 28.82 Diabetic neuropathy | 6 0.06 28.88 Diabetic retinal oedema | 6 0.06 28.94 Diabetic retinopathy | 2 0.02 28.96 Diagnostic procedure | 1 0.01 28.97 Diarrhoea | 27 0.27 29.24 Diffuse large B-cell lymphoma | 73 0.73 29.97 Diffuse large B-cell lymphoma stage II | 5 0.05 30.02 Discomfort | 1 0.01 30.03 Disturbance in social behaviour | 2 0.02 30.05 Diuretic therapy | 8 0.08 30.13 Diverticulitis | 2 0.02 30.15 Dizziness | 5 0.05 30.20 Drug abuse | 2 0.02 30.22 Drug dependence | 2 0.02 30.24 Drug hypersensitivity | 1 0.01 30.25 Dry eye | 2 0.02 30.27 Dry mouth | 2 0.02 30.29 Dry skin | 1 0.01 30.30 Duchenne muscular dystrophy | 1 0.01 30.31 Ductal adenocarcinoma of pancreas | 1 0.01 30.32 Duodenal ulcer | 1 0.01 30.33 Dwarfism | 88 0.88 31.21 Dyslipidaemia | 19 0.19 31.40 Dysmenorrhoea | 2 0.02 31.42 Dyspepsia | 81 0.81 32.23 Dysphagia | 1 0.01 32.24 Dyspnoea | 13 0.13 32.37 Dysthymic disorder | 1 0.01 32.38 Dystonia | 1 0.01 32.39 Dysuria | 7 0.07 32.46 Ear infection | 1 0.01 32.47 Eating disorder | 1 0.01 32.48 Elderly | 1 0.01 32.49 Electrocardiogram ST segment elevation | 1 0.01 32.50 Electrolyte substitution therapy | 2 0.02 32.52 Embolism | 1 0.01 32.53 Embolism venous | 1 0.01 32.54 Emergency care | 1 0.01 32.55 Emphysema | 16 0.16 32.71 Empty sella syndrome | 3 0.03 32.74 Endocarditis | 1 0.01 32.75 Endocarditis bacterial | 3 0.03 32.78 Endocrine disorder | 3 0.03 32.81 Enterocolitis | 4 0.04 32.85 Epilepsy | 28 0.28 33.13 Epstein-Barr virus infection | 1 0.01 33.14 Eructation | 1 0.01 33.15 Erythema nodosum | 1 0.01 33.16 Escherichia infection | 1 0.01 33.17 Essential hypertension | 5 0.05 33.22 Ex-tobacco user | 1 0.01 33.23 Excessive dietary fibre intake | 1 0.01 33.24 Extrapyramidal disorder | 2 0.02 33.26 Eye disorder | 2 0.02 33.28 Eye pain | 1 0.01 33.29 Eye pruritus | 1 0.01 33.30 Eye swelling | 1 0.01 33.31 Facial spasm | 1 0.01 33.32 Faciodigitogenital dysplasia | 1 0.01 33.33 Factor VIII deficiency | 4 0.04 33.37 Faecaloma | 1 0.01 33.38 Faeces hard | 2 0.02 33.40 Faeces soft | 1 0.01 33.41 Failure to thrive | 9 0.09 33.50 Familial mediterranean fever | 2 0.02 33.52 Fatigue | 10 0.10 33.62 Fatty acid deficiency | 1 0.01 33.63 Febrile neutropenia | 2 0.02 33.65 Feeling abnormal | 1 0.01 33.66 Fibromyalgia | 26 0.26 33.92 Fistula | 2 0.02 33.94 Flatulence | 2 0.02 33.96 Fluid imbalance | 1 0.01 33.97 Fluid replacement | 1 0.01 33.98 Fluid retention | 5 0.05 34.03 Focal segmental glomerulosclerosis | 1 0.01 34.04 Foetal exposure during pregnancy | 7 0.07 34.11 Foetal growth restriction | 1 0.01 34.12 Folliculitis | 2 0.02 34.14 Fungal infection | 3 0.03 34.17 Fungal skin infection | 1 0.01 34.18 Gait disturbance | 7 0.07 34.25 Gallbladder cancer | 3 0.03 34.28 Gastric cancer | 4 0.04 34.32 Gastric disorder | 9 0.09 34.41 Gastric operation | 2 0.02 34.43 Gastric pH decreased | 3 0.03 34.46 Gastric ulcer | 4 0.04 34.50 Gastritis | 17 0.17 34.67 Gastritis prophylaxis | 8 0.08 34.75 Gastroenteritis | 7 0.07 34.82 Gastrointestinal disorder | 9 0.09 34.91 Gastrointestinal infection | 1 0.01 34.92 Gastrointestinal perforation | 1 0.01 34.93 Gastrointestinal stromal tumour | 2 0.02 34.95 Gastrooesophageal reflux disease | 244 2.44 37.39 Gaucher's disease | 1 0.01 37.40 Generalised tonic-clonic seizure | 3 0.03 37.43 Genital herpes | 3 0.03 37.46 Germ cell cancer | 3 0.03 37.49 Gingivitis | 1 0.01 37.50 Glaucoma | 10 0.10 37.60 Glioblastoma | 6 0.06 37.66 Glioblastoma multiforme | 4 0.04 37.70 Glioma | 1 0.01 37.71 Glomerulonephritis chronic | 1 0.01 37.72 Glossitis | 1 0.01 37.73 Glucose tolerance impaired | 2 0.02 37.75 Goitre | 2 0.02 37.77 Gonadal dysgenesis | 2 0.02 37.79 Gout | 3 0.03 37.82 Gouty arthritis | 1 0.01 37.83 Granulomatosis with polyangiitis | 15 0.15 37.98 Growth hormone deficiency | 86 0.86 38.84 Growth retardation | 3 0.03 38.87 Guttate psoriasis | 1 0.01 38.88 HER-2 positive breast cancer | 18 0.18 39.06 HIV infection | 130 1.30 40.36 Haematochezia | 1 0.01 40.37 Haematological malignancy | 7 0.07 40.44 Haemoglobin decreased | 1 0.01 40.45 Haemolytic uraemic syndrome | 10 0.10 40.55 Haemorrhage intracranial | 1 0.01 40.56 Haemosiderosis | 1 0.01 40.57 Haemostasis | 2 0.02 40.59 Hairy cell leukaemia | 1 0.01 40.60 Head and neck cancer | 5 0.05 40.65 Headache | 31 0.31 40.96 Hearing impaired | 1 0.01 40.97 Heart disease congenital | 1 0.01 40.98 Heart rate irregular | 4 0.04 41.02 Heart transplant | 18 0.18 41.20 Heart valve replacement | 1 0.01 41.21 Hepatic cancer | 12 0.12 41.33 Hepatic cirrhosis | 4 0.04 41.37 Hepatitis | 2 0.02 41.39 Hepatitis B | 3 0.03 41.42 Hepatitis C | 24 0.24 41.66 Hepatobiliary cancer | 1 0.01 41.67 Hepatocellular carcinoma | 4 0.04 41.71 Hepatorenal syndrome | 1 0.01 41.72 Herpes virus infection | 1 0.01 41.73 Herpes zoster | 3 0.03 41.76 Hiatus hernia | 21 0.21 41.97 Hiccups | 1 0.01 41.98 High risk pregnancy | 2 0.02 42.00 Hodgkin's disease | 28 0.28 42.28 Hormone level abnormal | 1 0.01 42.29 Hormone replacement therapy | 6 0.06 42.35 Hormone therapy | 3 0.03 42.38 Hot flush | 3 0.03 42.41 Hyper IgD syndrome | 1 0.01 42.42 Hypercalcaemia | 2 0.02 42.44 Hyperchlorhydria | 1 0.01 42.45 Hypercholesterolaemia | 26 0.26 42.71 Hyperglycaemia | 1 0.01 42.72 Hyperkeratosis | 1 0.01 42.73 Hyperkinesia | 1 0.01 42.74 Hyperlipidaemia | 14 0.14 42.88 Hyperparathyroidism primary | 2 0.02 42.90 Hyperphosphataemia | 1 0.01 42.91 Hyperpituitarism | 4 0.04 42.95 Hypersensitivity | 17 0.17 43.12 Hypersomnia | 1 0.01 43.13 Hypertension | 230 2.30 45.43 Hyperthyroidism | 1 0.01 45.44 Hypertonic bladder | 2 0.02 45.46 Hyperuricaemia | 14 0.14 45.60 Hyperventilation | 1 0.01 45.61 Hypochondroplasia | 1 0.01 45.62 Hypoglycaemia | 3 0.03 45.65 Hypogonadism | 1 0.01 45.66 Hypokalaemia | 7 0.07 45.73 Hyponatraemia | 3 0.03 45.76 Hypopharyngeal cancer | 2 0.02 45.78 Hypopituitarism | 55 0.55 46.33 Hypotension | 4 0.04 46.37 Hypothalamo-pituitary disorder | 21 0.21 46.58 Hypothyroidism | 36 0.36 46.94 Ill-defined disorder | 6 0.06 47.00 Immune system disorder | 2 0.02 47.02 Immune thrombocytopenic purpura | 9 0.09 47.11 Immunology test abnormal | 1 0.01 47.12 Immunosuppressant drug therapy | 2 0.02 47.14 Immunosuppression | 13 0.13 47.27 Impaired gastric emptying | 5 0.05 47.32 Implant site reaction | 1 0.01 47.33 Inappropriate antidiuretic hormone se.. | 1 0.01 47.34 Incontinence | 1 0.01 47.35 Infantile spasms | 2 0.02 47.37 Infection | 7 0.07 47.44 Infection prophylaxis | 9 0.09 47.53 Inflammation | 4 0.04 47.57 Inflammatory pain | 1 0.01 47.58 Influenza | 3 0.03 47.61 Influenza like illness | 2 0.02 47.63 Infusion related reaction | 1 0.01 47.64 Inhalation therapy | 2 0.02 47.66 Insomnia | 38 0.38 48.04 Intentional product misuse | 1 0.01 48.05 Interstitial lung disease | 4 0.04 48.09 Intervertebral disc protrusion | 5 0.05 48.14 Intracranial venous sinus thrombosis | 2 0.02 48.16 Intraductal proliferative breast lesion | 1 0.01 48.17 Intraocular pressure increased | 2 0.02 48.19 Invasive ductal breast carcinoma | 1 0.01 48.20 Iron deficiency | 1 0.01 48.21 Iron deficiency anaemia | 3 0.03 48.24 Iron overload | 2 0.02 48.26 Irritable bowel syndrome | 2 0.02 48.28 Ischaemia | 1 0.01 48.29 Ischaemic heart disease prophylaxis | 2 0.02 48.31 Ischaemic stroke | 1 0.01 48.32 Jaw fracture | 2 0.02 48.34 Joint swelling | 1 0.01 48.35 Juvenile idiopathic arthritis | 9 0.09 48.44 Kaposi's sarcoma AIDS related | 7 0.07 48.51 Kidney transplant rejection | 1 0.01 48.52 Klebsiella infection | 4 0.04 48.56 Knee arthroplasty | 3 0.03 48.59 Knee operation | 1 0.01 48.60 Lacunar infarction | 1 0.01 48.61 Large cell lung cancer | 3 0.03 48.64 Left ventricular dysfunction | 1 0.01 48.65 Leukaemia | 5 0.05 48.70 Leukopenia | 1 0.01 48.71 Ligament injury | 1 0.01 48.72 Limb discomfort | 5 0.05 48.77 Lipids abnormal | 2 0.02 48.79 Lipids increased | 3 0.03 48.82 Liver disorder | 4 0.04 48.86 Liver transplant | 1 0.01 48.87 Local anaesthesia | 1 0.01 48.88 Loss of consciousness | 3 0.03 48.91 Low density lipoprotein increased | 1 0.01 48.92 Lower respiratory tract infection | 1 0.01 48.93 Lower respiratory tract infection viral | 1 0.01 48.94 Lung adenocarcinoma | 3 0.03 48.97 Lung adenocarcinoma stage 0 | 1 0.01 48.98 Lung carcinoma cell type unspecified .. | 3 0.03 49.01 Lung disorder | 5 0.05 49.06 Lung infection | 2 0.02 49.08 Lung infiltration | 1 0.01 49.09 Lung neoplasm malignant | 42 0.42 49.51 Lung squamous cell carcinoma stage III | 6 0.06 49.57 Lung transplant | 1 0.01 49.58 Lupus endocarditis | 1 0.01 49.59 Lupus nephritis | 23 0.23 49.82 Lymphocytic leukaemia | 3 0.03 49.85 Lymphocytic lymphoma | 3 0.03 49.88 Lymphoma | 19 0.19 50.07 Macular degeneration | 1 0.01 50.08 Major depression | 12 0.12 50.20 Malaise | 4 0.04 50.24 Malignant ascites | 1 0.01 50.25 Malignant glioma | 2 0.02 50.27 Malignant histiocytosis | 1 0.01 50.28 Malignant lymphoid neoplasm | 7 0.07 50.35 Malignant mediastinal neoplasm | 1 0.01 50.36 Malignant melanoma | 18 0.18 50.54 Malignant neoplasm of auricular carti.. | 1 0.01 50.55 Malignant neoplasm of eyelid | 1 0.01 50.56 Malignant neoplasm of pleura | 2 0.02 50.58 Malignant neoplasm of uterine adnexa | 10 0.10 50.68 Malignant respiratory tract neoplasm | 30 0.30 50.98 Malignant urinary tract neoplasm | 17 0.17 51.15 Mania | 3 0.03 51.18 Mantle cell lymphoma | 4 0.04 51.22 Maternal exposure timing unspecified | 3 0.03 51.25 Medical device complication | 1 0.01 51.26 Memory impairment | 4 0.04 51.30 Meningitis | 7 0.07 51.37 Meningitis enterococcal | 1 0.01 51.38 Menometrorrhagia | 2 0.02 51.40 Menopausal symptoms | 7 0.07 51.47 Menopause | 2 0.02 51.49 Menorrhagia | 2 0.02 51.51 Menstrual cycle management | 5 0.05 51.56 Menstruation irregular | 2 0.02 51.58 Mental disorder | 2 0.02 51.60 Metastases to bone | 10 0.10 51.70 Metastases to bone marrow | 1 0.01 51.71 Metastases to central nervous system | 2 0.02 51.73 Metastases to liver | 10 0.10 51.83 Metastases to lung | 13 0.13 51.96 Metastases to lymph nodes | 1 0.01 51.97 Metastases to nervous system | 2 0.02 51.99 Metastases to peritoneum | 2 0.02 52.01 Metastatic carcinoid tumour | 1 0.01 52.02 Metastatic gastric cancer | 4 0.04 52.06 Metastatic malignant melanoma | 13 0.13 52.19 Metastatic renal cell carcinoma | 2 0.02 52.21 Metastatic squamous cell carcinoma | 1 0.01 52.22 Migraine | 24 0.24 52.46 Migraine prophylaxis | 1 0.01 52.47 Mineral supplementation | 5 0.05 52.52 Mitral valve prolapse | 1 0.01 52.53 Mitral valve replacement | 3 0.03 52.56 Mixed connective tissue disease | 2 0.02 52.58 Mood disorder due to a general medica.. | 6 0.06 52.64 Muckle-Wells syndrome | 1 0.01 52.65 Mucopolysaccharidosis II | 4 0.04 52.69 Multiple allergies | 9 0.09 52.78 Multiple sclerosis | 353 3.53 56.31 Multiple sclerosis relapse | 1 0.01 56.32 Muscle disorder | 1 0.01 56.33 Muscle relaxant therapy | 6 0.06 56.39 Muscle spasms | 22 0.22 56.61 Muscle spasticity | 3 0.03 56.64 Muscular weakness | 1 0.01 56.65 Musculoskeletal discomfort | 1 0.01 56.66 Musculoskeletal pain | 1 0.01 56.67 Musculoskeletal stiffness | 1 0.01 56.68 Myalgia | 4 0.04 56.72 Myasthenia gravis | 1 0.01 56.73 Mycosis fungoides | 3 0.03 56.76 Myelodysplastic syndrome | 6 0.06 56.82 Myelofibrosis | 4 0.04 56.86 Myocardial infarction | 21 0.21 57.07 Myocardial ischaemia | 6 0.06 57.13 Myocarditis | 1 0.01 57.14 Myoclonus | 4 0.04 57.18 Nail disorder | 1 0.01 57.19 Nasal congestion | 2 0.02 57.21 Nasopharyngitis | 10 0.10 57.31 Nausea | 38 0.38 57.69 Neck pain | 2 0.02 57.71 Neck surgery | 1 0.01 57.72 Negative thoughts | 8 0.08 57.80 Neoplasm | 1 0.01 57.81 Neoplasm malignant | 29 0.29 58.10 Neoplasm prophylaxis | 1 0.01 58.11 Neoplasm prostate | 2 0.02 58.13 Neovascular age-related macular degen.. | 16 0.16 58.29 Nephrogenic anaemia | 3 0.03 58.32 Nephrosclerosis | 2 0.02 58.34 Nephrotic syndrome | 1 0.01 58.35 Nerve injury | 3 0.03 58.38 Nervous system disorder | 16 0.16 58.54 Nervousness | 10 0.10 58.64 Neuralgia | 18 0.18 58.82 Neuroblastoma | 3 0.03 58.85 Neuroendocrine carcinoma metastatic | 2 0.02 58.87 Neuroendocrine tumour | 7 0.07 58.94 Neurogenic bladder | 1 0.01 58.95 Neuropathy peripheral | 15 0.15 59.10 Neutropenia | 3 0.03 59.13 Niemann-Pick disease | 1 0.01 59.14 Nightmare | 1 0.01 59.15 Nocturia | 1 0.01 59.16 Non-Hodgkin's lymphoma | 23 0.23 59.39 Non-Hodgkin's lymphoma unspecified hi.. | 5 0.05 59.44 Non-small cell lung cancer | 26 0.26 59.70 Non-small cell lung cancer stage IV | 2 0.02 59.72 Noonan syndrome | 2 0.02 59.74 Normal tension glaucoma | 1 0.01 59.75 Nuclear magnetic resonance imaging ab.. | 1 0.01 59.76 Nutritional supplementation | 12 0.12 59.88 Obesity | 4 0.04 59.92 Obsessive-compulsive disorder | 6 0.06 59.98 Obstructive airways disorder | 1 0.01 59.99 Obstructive uropathy | 1 0.01 60.00 Oedema | 8 0.08 60.08 Oedema due to cardiac disease | 1 0.01 60.09 Oedema peripheral | 1 0.01 60.10 Oesophageal candidiasis | 1 0.01 60.11 Oesophageal carcinoma | 3 0.03 60.14 Oesophageal disorder | 1 0.01 60.15 Oesophageal ulcer | 1 0.01 60.16 Oestradiol | 1 0.01 60.17 Oestrogen replacement therapy | 1 0.01 60.18 Off label use | 25 0.25 60.43 Open angle glaucoma | 3 0.03 60.46 Oral contraception | 1 0.01 60.47 Oral mucosal blistering | 1 0.01 60.48 Oral pain | 1 0.01 60.49 Organising pneumonia | 1 0.01 60.50 Oropharyngeal pain | 1 0.01 60.51 Osteitis | 2 0.02 60.53 Osteitis deformans | 1 0.01 60.54 Osteoarthritis | 6 0.06 60.60 Osteolysis | 1 0.01 60.61 Osteomyelitis | 2 0.02 60.63 Osteopenia | 33 0.33 60.96 Osteopetrosis | 1 0.01 60.97 Osteoporosis | 122 1.22 62.19 Osteoporosis postmenopausal | 1 0.01 62.20 Osteoporosis prophylaxis | 3 0.03 62.23 Ovarian cancer | 24 0.24 62.47 Ovarian cyst | 1 0.01 62.48 Overweight | 1 0.01 62.49 Pain | 122 1.22 63.71 Pain in extremity | 8 0.08 63.79 Palliative care | 2 0.02 63.81 Palmar-plantar erythrodysaesthesia sy.. | 1 0.01 63.82 Pancreatic carcinoma | 26 0.26 64.08 Pancreatic insufficiency | 2 0.02 64.10 Pancreatic neuroendocrine tumour | 2 0.02 64.12 Pancreatic neuroendocrine tumour meta.. | 1 0.01 64.13 Pancreatitis | 2 0.02 64.15 Panic attack | 7 0.07 64.22 Panic reaction | 1 0.01 64.23 Paraneoplastic dermatomyositis | 1 0.01 64.24 Paraproteinaemia | 3 0.03 64.27 Parkinson's disease | 1 0.01 64.28 Parkinsonism | 3 0.03 64.31 Paronychia | 4 0.04 64.35 Paroxysmal nocturnal haemoglobinuria | 12 0.12 64.47 Partial seizures | 2 0.02 64.49 Pathogen resistance | 5 0.05 64.54 Pelvic pain | 1 0.01 64.55 Pemphigus | 1 0.01 64.56 Pericardial effusion | 1 0.01 64.57 Pericarditis | 1 0.01 64.58 Periodic limb movement disorder | 1 0.01 64.59 Peripheral arterial occlusive disease | 10 0.10 64.69 Peripheral swelling | 4 0.04 64.73 Peripheral vascular disorder | 1 0.01 64.74 Peripheral venous disease | 1 0.01 64.75 Peritoneal dialysis | 4 0.04 64.79 Personality disorder | 1 0.01 64.80 Pharyngitis | 1 0.01 64.81 Phenylketonuria | 1 0.01 64.82 Pituitary infarction | 1 0.01 64.83 Pituitary tumour | 2 0.02 64.85 Pituitary-dependent Cushing's syndrome | 1 0.01 64.86 Plasma cell myeloma | 54 0.54 65.40 Pleural mesothelioma | 2 0.02 65.42 Pneumonia | 18 0.18 65.60 Pneumonia aspiration | 1 0.01 65.61 Pneumonitis | 1 0.01 65.62 Polycystic ovaries | 4 0.04 65.66 Polymyositis | 1 0.01 65.67 Polyneuropathy | 1 0.01 65.68 Polyuria | 4 0.04 65.72 Portopulmonary hypertension | 1 0.01 65.73 Post herpetic neuralgia | 1 0.01 65.74 Post-traumatic stress disorder | 2 0.02 65.76 Postmenopause | 3 0.03 65.79 Postoperative analgesia | 1 0.01 65.80 Postoperative care | 4 0.04 65.84 Postpartum hypopituitarism | 1 0.01 65.85 Prader-Willi syndrome | 3 0.03 65.88 Pregnancy | 1 0.01 65.89 Premedication | 51 0.51 66.40 Premenstrual dysphoric disorder | 4 0.04 66.44 Premenstrual syndrome | 2 0.02 66.46 Procedural pain | 6 0.06 66.52 Product use issue | 2 0.02 66.54 Product used for unknown indication | 1,582 15.82 82.36 Productive cough | 1 0.01 82.37 Prophylaxis | 107 1.07 83.44 Prophylaxis against HIV infection | 3 0.03 83.47 Prophylaxis against dehydration | 2 0.02 83.49 Prophylaxis against gastrointestinal .. | 9 0.09 83.58 Prophylaxis against graft versus host.. | 5 0.05 83.63 Prophylaxis against transplant reject.. | 8 0.08 83.71 Prophylaxis of nausea and vomiting | 2 0.02 83.73 Prostate cancer | 13 0.13 83.86 Prostate cancer metastatic | 9 0.09 83.95 Prostatic disorder | 3 0.03 83.98 Prostatomegaly | 3 0.03 84.01 Pruritus | 5 0.05 84.06 Psoriasis | 153 1.53 85.59 Psoriatic arthropathy | 21 0.21 85.80 Psychomotor hyperactivity | 1 0.01 85.81 Psychotic disorder | 3 0.03 85.84 Pulmonary arterial hypertension | 83 0.83 86.67 Pulmonary embolism | 3 0.03 86.70 Pulmonary fibrosis | 1 0.01 86.71 Pulmonary granuloma | 3 0.03 86.74 Pulmonary hypertension | 29 0.29 87.03 Pulmonary thrombosis | 1 0.01 87.04 Pustular psoriasis | 112 1.12 88.16 Pyrexia | 24 0.24 88.40 Rash | 3 0.03 88.43 Rectal cancer | 3 0.03 88.46 Rectosigmoid cancer | 4 0.04 88.50 Reflux gastritis | 2 0.02 88.52 Relapsing-remitting multiple sclerosis | 33 0.33 88.85 Relaxation therapy | 9 0.09 88.94 Renal aplasia | 1 0.01 88.95 Renal cancer | 27 0.27 89.22 Renal cell carcinoma | 20 0.20 89.42 Renal colic | 1 0.01 89.43 Renal disorder | 1 0.01 89.44 Renal osteodystrophy | 1 0.01 89.45 Renal transplant | 10 0.10 89.55 Renal tubular acidosis | 1 0.01 89.56 Respiratory disorder | 3 0.03 89.59 Respiratory failure | 1 0.01 89.60 Respiratory therapy | 4 0.04 89.64 Respiratory tract infection | 1 0.01 89.65 Restless legs syndrome | 6 0.06 89.71 Restlessness | 2 0.02 89.73 Retinal oedema | 1 0.01 89.74 Retroperitoneal cancer | 1 0.01 89.75 Reverse tri-iodothyronine increased | 1 0.01 89.76 Rheumatic disorder | 4 0.04 89.80 Rheumatoid arthritis | 229 2.29 92.09 Rhinitis | 1 0.01 92.10 Rhinitis allergic | 13 0.13 92.23 Richter's syndrome | 1 0.01 92.24 Riley-Day syndrome | 1 0.01 92.25 Routine health maintenance | 7 0.07 92.32 SLE arthritis | 1 0.01 92.33 Salivary gland cancer | 2 0.02 92.35 Sarcoidosis | 1 0.01 92.36 Scar | 1 0.01 92.37 Schizoaffective disorder | 3 0.03 92.40 Schizophrenia | 83 0.83 93.23 Schizophrenia, disorganised type | 7 0.07 93.30 Schizophrenia, paranoid type | 67 0.67 93.97 Schizophrenia, undifferentiated type | 4 0.04 94.01 Sciatica | 1 0.01 94.02 Scleroderma | 7 0.07 94.09 Seasonal allergy | 8 0.08 94.17 Secondary hypothyroidism | 1 0.01 94.18 Secondary progressive multiple sclero.. | 1 0.01 94.19 Secretion discharge | 1 0.01 94.20 Sedation | 8 0.08 94.28 Seizure | 33 0.33 94.61 Seizure cluster | 1 0.01 94.62 Sensory disturbance | 1 0.01 94.63 Sepsis | 1 0.01 94.64 Silver-Russell syndrome | 1 0.01 94.65 Sinus disorder | 2 0.02 94.67 Sinus tachycardia | 1 0.01 94.68 Sinusitis | 11 0.11 94.79 Sjogren's syndrome | 2 0.02 94.81 Skeletal injury | 3 0.03 94.84 Skin cancer | 1 0.01 94.85 Skin disorder | 2 0.02 94.87 Skin lesion | 1 0.01 94.88 Sleep apnoea syndrome | 1 0.01 94.89 Sleep disorder | 72 0.72 95.61 Sleep disorder therapy | 3 0.03 95.64 Small cell lung cancer | 3 0.03 95.67 Small for dates baby | 2 0.02 95.69 Small intestine carcinoma | 3 0.03 95.72 Small intestine carcinoma metastatic | 3 0.03 95.75 Smoking cessation therapy | 12 0.12 95.87 Sneezing | 1 0.01 95.88 Social phobia | 1 0.01 95.89 Soft tissue sarcoma | 3 0.03 95.92 Spinal column stenosis | 1 0.01 95.93 Spinal disorder | 1 0.01 95.94 Spinal pain | 4 0.04 95.98 Sputum purulent | 1 0.01 95.99 Squamous cell carcinoma of head and n.. | 4 0.04 96.03 Squamous cell carcinoma of skin | 1 0.01 96.04 Staphylococcal infection | 1 0.01 96.05 Status asthmaticus | 2 0.02 96.07 Status epilepticus | 4 0.04 96.11 Stem cell transplant | 2 0.02 96.13 Stent placement | 15 0.15 96.28 Stomatitis | 4 0.04 96.32 Stress | 1 0.01 96.33 Sturge-Weber syndrome | 2 0.02 96.35 Subileus | 1 0.01 96.36 Supplementation therapy | 30 0.30 96.66 Supraventricular tachycardia | 1 0.01 96.67 Surgery | 2 0.02 96.69 Systemic lupus erythematosus | 14 0.14 96.83 T-cell type acute leukaemia | 12 0.12 96.95 Tachyphrenia | 13 0.13 97.08 Tendonitis | 1 0.01 97.09 Tenosynovitis | 1 0.01 97.10 Tension headache | 1 0.01 97.11 Thrombocytopenia | 6 0.06 97.17 Thrombosis | 16 0.16 97.33 Thrombosis prophylaxis | 16 0.16 97.49 Thyroid cancer | 1 0.01 97.50 Thyroid disorder | 29 0.29 97.79 Thyroid operation | 1 0.01 97.80 Thyroid therapy | 1 0.01 97.81 Thyroidectomy | 1 0.01 97.82 Tinea cruris | 1 0.01 97.83 Tobacco user | 4 0.04 97.87 Tongue neoplasm malignant stage unspe.. | 1 0.01 97.88 Tooth abscess | 1 0.01 97.89 Toothache | 1 0.01 97.90 Transient ischaemic attack | 8 0.08 97.98 Transplant rejection | 2 0.02 98.00 Tremor | 3 0.03 98.03 Trigeminal neuralgia | 5 0.05 98.08 Tumour pain | 1 0.01 98.09 Turner's syndrome | 16 0.16 98.25 Type 1 diabetes mellitus | 6 0.06 98.31 Type 2 diabetes mellitus | 65 0.65 98.96 Type IIa hyperlipidaemia | 1 0.01 98.97 Ulcer | 9 0.09 99.06 Underweight | 2 0.02 99.08 Upper limb fracture | 1 0.01 99.09 Upper respiratory tract infection | 4 0.04 99.13 Upper respiratory tract inflammation | 7 0.07 99.20 Ureteral disorder | 1 0.01 99.21 Urinary incontinence | 2 0.02 99.23 Urinary tract disorder | 1 0.01 99.24 Urinary tract infection | 8 0.08 99.32 Urticaria | 3 0.03 99.35 Uterine cancer | 2 0.02 99.37 Vaginal haemorrhage | 1 0.01 99.38 Vascular graft | 1 0.01 99.39 Vasculitis | 2 0.02 99.41 Vasogenic cerebral oedema | 1 0.01 99.42 Venous occlusion | 1 0.01 99.43 Venous thrombosis | 3 0.03 99.46 Ventricular extrasystoles | 2 0.02 99.48 Ventricular tachycardia | 2 0.02 99.50 Vertebrobasilar insufficiency | 1 0.01 99.51 Vertigo | 2 0.02 99.53 Visual impairment | 1 0.01 99.54 Vitamin B12 decreased | 1 0.01 99.55 Vitamin B12 deficiency | 4 0.04 99.59 Vitamin D deficiency | 5 0.05 99.64 Vitamin supplementation | 10 0.10 99.74 Vomiting | 7 0.07 99.81 Vulval cancer | 1 0.01 99.82 Vulvovaginal candidiasis | 1 0.01 99.83 Waldenstrom's macroglobulinaemia | 4 0.04 99.87 Weight decreased | 1 0.01 99.88 Wheezing | 8 0.08 99.96 White blood cell count decreased | 1 0.01 99.97 Wound infection | 2 0.02 99.99 Wound treatment | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017